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Abstract 
Human cytochrome P450 3A7 (CYP3A7) and
cytochrome P450 3A4 (CYP3A4) are hepatic
metabolising enzymes which participates in
the biotransformation of endo- and exogenous
substances in foetuses and neonates respec-
tively. These CYP3A enzymes display an
inverse relationship: CYP3A7 is the dominant
enzyme in the foetal liver, whereas the expres-
sion of CYP3A4 is low. After parturition there is
a shift in the expression, thus CYP3A7 is down
regulated, while the level of CYP3A4 gradually
increases and becomes the dominant
metabolising CYP3A enzyme in the adult. The
minipig is increasingly being used as a model
for humans in biomedical studies, because of
its many similarities with the human physiolo-
gy and anatomy. The aim of this study was to
examine whether, as in humans, a shift is
seen in the hepatic expression of a CYP3A7-
like enzyme to cytochrome P450 3A29
(CYP3A29) (an orthologue to the human
CYP3A4) in minipigs. This was elucidated by
examining the hepatic mRNA expression of
CYP3A7 and CYP3A29 in 39 foetuses and new-
born Göttingen minipigs using quantitative
real time polymerase chain reaction (qPCR).
Furthermore the immunochemical level of
CYP3A7-LE and CYP3A29 was measured in
liver microsomes using western blotting. The
expression of CYP3A29 was approximately 9-
fold greater in neonates compared to foetuses,
and a similar difference was reflected on the
immunochemical level. It was not possible to
detect a significant level of foetal CYP3A7
mRNA, but immunoblotting showed a visible
difference depending on age. This study
demonstrates an increase in the expression of
CYP3A29, the CYP3A4 orthologue in perinatal
minipigs as in humans, which suggests that
the minipig could be a good model when test-
ing for human foetal toxicity towards CYP3A4
substrates.
Introduction
To gain knowledge of pharmacological and
toxicological properties of new chemical com-
pounds they are studied using laboratory ani-
mals. However some metabolic difference
exists among species, which complicates the
extrapolation of results from animal models to
humans.1 For this reason it is relevant to clari-
fy, whether the species used in these experi-
ments have metabolising characteristics com-
parable to humans. 
Since the 1980s, the minipig has been a
popular alternative to the traditional non-
rodent species in pharmacology and toxicology
studies because of its many similarities with
the human physiology and anatomy.2-4 It has
been shown that the expression of a minipig
cytochrome P450 3A (CYP3A) enzyme is com-
parable with the human cytochrome P450 3A4
(CYP3A4) enzyme.5,6 However it is unknown
whether the minipig foetus and the human
foetus express comparable metabolising
enzymes.
Human CYP3A constitute some of the most
important hepatic isoenzymes as they account
for 30 percent of the total cytochrome P450
complex.7 It is assumed that CYP3A isoen-
zymes are involved in the biotransformation of
more than half of the therapeutic agents which
undergo metabolic oxidation.8 Two human
CYP3A, CYP3A4 and cytochrome P450 3A7
(CYP3A7), exhibit an inverse expression pat-
tern.9-11 In minipigs however only one of these
isoenzymes, the CYP3A4 like enzyme, has
been characterized and the mRNA sequenced.
CYP3A7 has been termed foetus-specific, as
this is the dominant isoenzyme in the liver of
human foetuses until birth. Its hepatic expres-
sion has been demonstrated as early as 50 days
after conception.9,12-14 Around time of birth the
expression of CYP3A7 is remarkably reduced
whereas the expression of CYP3A4 gradually
increases. Within the first year of life, the
hepatic CYP3A7 level declines to very low
quantities and CYP3A4 becomes the dominant
isoenzyme in the liver of adult.9-11,15
During foetal development the hepatic
CYP3A4 expression accounts for less than 10%
of the adult level until birth, after which the
expression gradually increases and becomes
the dominant CYP3A isoform in the liver of
adults,9,16 playing a considerable role in the
biotransformation of xenobiotics.17
The cytochrome P450 3A29 (CYP3A29)
isoenzyme of pigs and minipigs have been
shown to have similar enzymatic activity to the
human CYP3A46,18,19 and Anzenbacherova et
al.20 found that the binding site of CYP3A29
and CYP3A4 is well conserved, suggesting that
these enzymes share common characteristics.
As the human foetus has a metabolism inde-
pendently of the mother, it is important that
the species used to test for foetal toxicity
exhibit a metabolism resembling the metabo-
lism of human foetuses. The animal species
most used when testing for teratogenicity are
the mouse and rat classified as rodents, and
the rabbit as the non-rodent species.21,22
Since minipigs increasingly are being used
in pharmacological and toxicological tests, the
aim of this study was, to examine the hepatic
expression profile of CYP3A enzymes of foetus-
es and newborn Göttingen minipigs. This was
investigated to clarify whether there exists a
comparable shift in the expression from a
CYP3A7-like enzyme to CYP3A29 around the
time of birth, supporting the use of this
species as model for human foetal toxicity.
Materials and Methods
Animals
Liver tissue was obtained from 39 Göttingen
minipigs: 19 foetuses (9 males and 10
females) approximately 100 days after fertil-
ization and 20 neonates (10 males and 10
females) about 24 hours old. Dams were fed
commercial chow restrictively and provided
with water ad libitum. No CYP induction was
performed. The dams were killed by use of cap-
tive bolt pistol and exsanguination. The pla-
centa containing the foetuses was retrieved
from the dam just after it was killed. This pro-
cedure was chosen to avoid any influence on
gene expression. The foetuses were killed by
decapitation and neonates were killed by a
blow to the head followed by decapitation and
exsanguination. Handling of the animals was
performed by experienced, authorized people
and in accordance to Danish legislation. Liver
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tissue was removed and frozen within 10 to 15
minutes. Liver samples for RNA later were
obtained from lobus hepatis sinister medialis,
the rest of the liver was put on dry ice and
afterwards stored at -80ºC. The animals were
kindly donated by Ellegaard Göttingen Minipig
A/S, Dalmose, Denmark.Chemicals
RNA isolation kit: NucleoSpin RNA II from
Macherey-Nagel (AH diagnostics, Aarhus,
Denmark), C-03, RT2 First Strand Kit from
SABiosciences (Tebu-bio Aps., Roskilde,
Denmark), Real-Time PCR reaction kit the
LightCycler 480 SYBR Green I from Roche
Diagnostics (Mannheim, Germany), Primers
for the Real-Time PCR reaction were synthe-
sized by TAG Copenhagen A/S (Copenhagen,
Denmark). Gels for electrophoresis were pur-
chased from GE Healthcare (Waukesha, WI,
USA). The antibodies were obtained from
BioSite (San Diego, CA, USA) cat. # AP7898c
(CYP3A7), Gentest (Prague, Czech Republic)
cat. # 458254 (CYP3A4), GE Healthcare cat. #
RPN1004 (anti-rabbit) and Dako Denmark A/S
(Glostrup Denmark) code E0433 (anti-mouse).
All other chemicals were of analytical grade.  RNA extraction and first strandcDNA synthesis
Total RNA was extracted from about 30 mg
of frozen liver tissue stored in RNA later at -
18ºC using the NucleoSpin RNA II kit (AH diag-
nostics) following the kit manual. The RNA
concentration was determined by the Thermo
Scientific NanoDrop 1000 spectrophotometer
(Saveen Werner AB, Malmö, Sweden). Each
sample was diluted to 250 ng/μL and 1.6 μL
was treated with 0.4 μL DNA elimination
buffer by incubation at 42ºC in 5 minutes and
subsequently put on ice for at least 1 minute.
First Strand cDNA synthesis was performed
using C-03, RT2 First Strand Kit (Tebu-bio
Aps.) according to user's manual. Quantitative mRNA estimation,real-time polymerase chain reaction
Primers for CYP3A4 (human),23 CYP3A7
(human)16,24 and reference genes: RPL4, SDHA
and TBP (porcine)25 have been chosen on the
bases of existing literature. Finally porcine
primers were designed for CYP3A29 using a
primer design tool at the National Center for
Biotechnology Information (NCBI)
homepage.26 Nucleotide sequences, species
specificity and product sizes are listed in Table
1. Real-time PCR reaction was set up accord-
ing to kit manual and optimized with respect to
primer concentration, cDNA concentration and
annealing temperature. 
The final 20 μL PCR reactions contained 20
ng of transcribed RNA and the primer concen-
trations 1µm. The Multiwell Plate was loaded
into the LightCycler®480 (Roche) and the fol-
lowing PCR program was used: pre-incubation
for 2 min and then 40 cycles, denaturation 10s
at 95ºC, annealing 30s at 56ºC and synthesis 30
sec at 72ºC, followed by a melting curve analy-
sis. Negative controls were set up omitting
either the cDNA or primers.
Each sample and its associate CYP genes of
interest was normalized on the basis of the
mean of the three reference genes’ Cp values,
which served as an endogenous control func-
tioning as a baseline. Thus the results are
given as the relative expression of the gene of
interest compared to the reference genes,
using the formula: NCYP=2DCp, where NCYP is
the N-fold expression of the CYP gene relative
to baseline and DCp is the difference between
Cp(CYP) and Cp(mean reference genes).DNA isolation
Chromosomal  DNA was isolated using the
illustra triplePrep Kit from GE Healthcare accord-
ing to manual, and PCR reactions were set up
using 50 ng of DNA for each 20 μL reactions.Isolation of liver microsomes
The liver was homogenized in 15 mL 50 mM
Tris. HCl buffer containing 0.25 M sucrose and
1 mM ethylenediaminetetraacetic acid. The
homogenate was centrifuged at 9000xg at 4°C
for 30 minutes. Afterwards the supernatant
was transferred to new tubes and once again
centrifuged at 105,000xg at 4°C for 30 min-
utes. The supernatant was removed and the
pellet containing the microsomes was resus-
pended and homogenized in storage buffer
(0.154M KCl, 0.01M Hepes, 0.001M EDTA, 20%
glycerine, pH 7.6), put on straws and frozen in
liquid nitrogen.
Western blotting 
Microsomal protein (2 mg/mL, 20 μg/lane)
was separated by SDS-PAGE gel electrophore-
sis using the Multiphor II electrophoresis unit
(Pharmacia, LKB Biotechnology AB, Uppsala,
Sweden) and the Electrophoresis Power
Supply – EPS 3500 from Pharmacia LKB
Biotech. The proteins were transferred to a
Hybond-ECL (GE Healthcare) nitro-cellulose
membrane. The membrane was incubated 2
hours with the primary antibody, anti-human
CYP3A7, diluted 137.5 times in 2% skimmed
milk-TBS followed by the secondary antibody,
anti-rabbit IgG, and the bands were visualized
using the ECL reagents in combination with
the UVP BioSpectrum® Imaging System
(Upland, CA, USA). Afterwards the membrane
was stripped, and incubation was repeated
with anti-human CYP3A4 as the primary anti-
body and anti-mouse IgG as the secondary
antibody, as described earlier.6 Human recom-
binant CYP3A7 and CYP3A4 proteins were
used as positive controls.Statistics
Univariate linear regression followed by the
natural logarithm transformation and the
analysis of variance (ANOVA) were conducted
using R commander, version 1.5-4.27 P<0.05
was accepted as a statistically significant dif-
ference. The factors age and sex were exam-
ined against CYP3A29 and CYP3A7-LE and
additionally it was investigated if there were
possible interaction between these factors. For
the foetuses a time variable was included to
investigate, whether gene expression was
influenced by the time passed in minutes,
from the dam was killed, to the foetal organs
were frozen. 
Article
Table 1. Primers used for polymerase chain reaction, product size and species specificity
of the primers.
Gene Primer (5'-3') Product size GeneBank  
(bp) accession number
CYP3A29 (f) GGGACCGTGGTGGTGGTGCCAGT 151 NM_214423*
(sus scrofa) (r) TGCGGGGTCCAGTCCCAAAGGGCA 
CYP3A4 (f) TGGTGAATGAAACGCTCAGATTA 349 NM_01746023
(homo sapiens) (r) AGGGGGATCTGTGTTTCTTTACAA 
CYP3A7-1 (f) CCTTACCCCAATTCTTGAAGCA 198 NM_00076516
(homo sapiens) (r) TCCAGATCAGACAGAGCTTTGTG 
CYP3A7-2 (f) GATCTCATCCCAAACTTGGCCG 241 NM_00076524
(homo sapiens) (r) CATAGGCTGTTGACAGGTCATAAATA 
Reference gene
RPL4 (f) CAAGAGTAACTACAACCTTC 122 DQ84517625
(sus scrofa) (r) GAACTCTACGATGAATCTTC 
SDHA (f) CTACAAGGGGCAGGTTCTGA 141 DQ84517725
(sus scrofa) (r) AAGACAACGAGGTCCAGGAG 
TBP (f) AACAGTTCAGTAGTCATGAGCCAGA 153 DQ84517825
(sus scrofa) (r) AGATGTTCTCAAACGCTTCG 
f, forward; r, reverse. *Created using Primer BLAST, a primer design tool at the homepage of NCBI.26
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Results
Real-time polymerase chain reaction 
The expression of CYP3A7-LE and CYP3A29
were investigated and estimated from the
mRNA level in the liver of 19 foetuses and 20
neonates Göttingen minipigs. Results are
given as the relative expression of the respec-
tive CYP gene for the individual animal, that
is, they reflect how many times (N-fold) the
respective gene is expressed compared to the
reference genes. 
All of the Cp values for CYP3A7-LE were >35,
which means that it was not possible to
demonstrate an expression of CYP3A7-LE
mRNA in the liver from Göttingen minipigs
under the given circumstances. 
In general the relative expression of
CYP3A29 was higher for neonates than for foe-
tuses (Figure 1). This was confirmed by the
statistical data analysis, ANOVA, showing a
significant difference in the relative expres-
sion of CYP3A29 in neonates compared to foe-
tuses (P<5,208–16), foetuses mean 0.0461
(0.0371; 0.0649) and neonates mean 0.4252
(0.243; 0.7441). The difference in CYP3A29
depending on age is visualized in Figure 2.
CYP3A29 mRNA expression was approximately
9-fold higher in neonates compared to foetus-
es, corresponding to an up regulation of more
than 800% in comparison to foetuses. No sex
differences were detected (P=0.65).
Positive result were obtained using chromo-
somal DNA and the CYP3A29 primers, whereas
no amplification was obtained when using the
CYP3A7-LE primer pairs.Western blotting
Western blotting using a CYP3A7 primary
antibody revealed nice single bands, with the
immunochemically determined protein con-
centration being obviously higher for foetuses
than for neonates (Figure 3).
The immunochemically determined protein
concentration of CYP3A29 followed the same
pattern as the results obtained from real-time
PCR with highest concentration in the
neonates (Figure 3). 
Discussion
This is the first papers investigating and
comparing the hepatic expression of CYP3A29
between foetuses and neonates Göttingen
minipigs, and the first study that measures a
CYP3A7-like enzyme in Göttingen minipigs.
This is relevant as the human orthologues play
a detrimental role in metabolising several
xenobiotics in adults and foetuses respective-
ly.17,28 Since the minipig is used as a model for
humans in biomedical studies, it is important
to clarify, whether this species expresses com-
parable CYP enzymes to humans of similar
age.2,6 So far no single animal species stands
out as being the best model for human foetal
toxicity; however species used should exhibit
similar rates as well as pathways of xenobiotic
metabolism.22 The hepatic mRNA expression
and protein level of the isoenzymes CYP3A29
and a CYP3A7-like enzyme of Göttingen mini -
pig in the present study can provide valuable
references for evaluating the usefulness of
Göttingen minipig as model for human foetus-
es and neonates.
Results from human studies indicate that it
should have been possible to measure the
expression of a CYP3A7-like enzyme in both
foetuses (gestational day 100 out of 114) and
Article
Figure 1. The relative expression of CYP3A29 for each individual Göttingen minipig
depicted according to sex (pink: female, light blue: male). The animals were assigned con-
secutive laboratory numbers: animal no.1 to no. 19 are foetuses, while animal no. 20 to
no. 39 are neonates.
Figure 2. Box plot show-
ing the difference in the
relative expression of
CYP3A29 depending on
age (y-axis depicts the
∆Cp values).
Figure 3. Western blot for 10 foetuses, lane 1-10, and 9 neonates, lane 11-19, female
Göttingen minipigs. Upper lane incubated with anti-human CYP3A7, lower incubated
with anti-human CYP3A4.
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neonates (approximately 24 hours old)
Göttingen minipigs, if they transcribed such
an enzyme with a similar expression pattern
as CYP3A7 in humans.9,14,29 However this was
not possible at mRNA level. There can be sev-
eral potential explanations for this. It might be
that the Göttingen minipigs included in the
experiment did not express this gene, or, alter-
natively, the primers selected did not hybridize
well. However western blotting revealed nice
single bands and signals were visibly stronger
for foetuses than for newborn Göttingen
minipigs, indicating that there was a pre- or
post transcription down regulation of a
CYP3A7-like gene. This suggests that the
primers used for real-time PCR have not been
functional. Since the primers used in this
experiment were of human origin, it is likely,
that there exist some variation in the primer-
specific regions between the human CYP3A7
and a CYP3A7-like gene in Göttingen minipig.
Amplification reactions using chromosomal
DNA confirmed that the primer pairs for
CYP3A7 did not function, as no amplification
was seen. However the bands appearing in the
Western Blot could also be due to cross
hybridization to other CYP3A variant.
Results from real-time PCR revealed that
the relative expression of hepatic CYP3A29 in
Göttingen minipigs was significantly different
depending on age. This corresponds well with
published results from studies dealing with the
hepatic expression of CYP3A4 in human foe-
tuses and neonates.9,15,18 A similar up regula-
tion has been demonstrated for CYP3A4 in
humans. Lacroix et al.9 found that the hepatic
CYP3A4 mRNA level in human foetuses were
less than 10% of the adult level. Recently the
tissue distribution of CYP3A29 mRNA expres-
sion of Bama miniature pigs was investigated
using real-time PCR. This study demonstrated
an increasing hepatic mRNA expression level
in Bama miniature pigs with the age: new-
born, forty days, four months, six months and
two years.18 The increasing level of CYP3A29
with age is consistent with the up regulation
shown in neonates compared with foetuses.
When comparing the results from real-time
PCR and western blotting, these reflect similar
expression patterns with weak or even missing
for foetuses, whereas the bands are more pro-
nounced for neonates Göttingen minipigs in
line with the significant up regulation on
mRNA level. Although still weak, the bands for
CYP3A29 are visibly demonstrated for more
neonates than foetuses. It is most likely that
this tendency would have been more pro-
nounced if the experiment had included even
older minipigs.18
No sex difference of the relative CYP3A29
mRNA expression level appeared in neither
foetuses or newborn Göttingen minipigs. This
was in agreement with our expectations, as it
previously was shown, that hormones regu-
lates the CYP3A expression in pigs.23 Likewise
no significant sex differences have been found
for the hepatic CYP3A mRNA expression level
neither in human foetuses30 nor at the CYP3A4
protein level in men and women.7
It was also shown that there is a slight
interindividual variation in the CYP3A29
mRNA expression level. In this case this is
mainly attributed to the genetic difference
between individuals, as the Göttingen mini -
pigs is from an outbred population. Similar
results have been obtained for the CYP3A29
mRNA expression in Bama miniature pigs18
and for the CYP3A4 mRNA expression in
humans, where a tenfold variation has been
demonstrated.30 Other possible factors which
may have an influence on the expression level
are for example the environment, pathology,
hormonal or nutritional circumstances. These
factors have, as far as possible, been eliminat-
ed in this experiment by using Göttingen
minipigs of both sexes, bred under standard-
ized conditions in a pathogen-free environ-
ment.
In conclusion the present study demonstrat-
ed that an up regulation of CYP3A29 both on
transcriptional and translational level in
neonates compared with foetuses occur. This
shows that Göttingen minipigs exhibit a simi-
lar CYP3A4 like expression pattern as human
foetuses and neonates of comparable age, indi-
cating that the Göttingen minipig could be a
good model when testing for foetal toxicity.
References
1. Bogaards JJ, Bertrand M, Jackson P, et al.
Determining the best animal model for
human cytochrome P450 activities: a com-
parison of mouse, rat, rabbit, dog,
micropig, monkey and man. Xenobiotica
2000;30:1131-52.
2. Svendsen O. The minipig in toxicology.
Exp Toxicol Pathol 2006;57:335-9.
3. Meddahi A. Le miniporc comme modèle
expérimental. Sci Tech Anim Lab 1994;19:
11-27.
4. Bollen P, Ellegaard L. The Göttingen minip-
ig in pharmacology and toxicology.
Pharmacol Toxicol 1997;80:3-4.
5. Anzenbacher P, Soucek P, Anzenbacherova
E, et al. Presence and activity of
cytochrome P450 isoforms in minipig liver
microsomes. Comparison with human
liver samples. Drug Metab Dispos 1998;
26:56-9.
6. Skaanild MT, Friis C. Cytochrome P450 sex
differences in minipigs and conventional
pigs. Pharmacol Toxicol 1999;85:174-80.
7. Shimada T, Yamazaki H, Mimura M, et al.
Interindividual variations in human liver
cytochrome P-450 enzymes involved in the
oxidation of drugs, carcinogens and 
toxic chemicals: studies with liver micro-
somes of 30 Japanese and 30 Caucasians.
J Pharmacol Exp Ther 1994;270:414-23.
8. Wilkinson GR. Drug metabolism and vari-
ability among patients in drug response. N
Engl J Med 2005;352:2211-21.
9. Lacroix D, Sonnier M, Moncion A, et al.
Expression of CYP3A in the human liver --
evidence that the shift between CYP3A7
and CYP3A4 occurs immediately after
birth. Eur J Biochem 1997;247:625-34.
10. Nelson DR. The cytochrome p450 home-
page. Hum Genomics 2009;4:59-65. 
11. Danielson PB. The cytochrome P450
superfamily: biochemistry, evolution and
drug metabolism in humans. Curr Drug
Metab 2002;3:561-97.
12. Bieche I, Narjoz C, Asselah T, et al.
Reverse transcriptase-PCR quantification
of mRNA levels from cytochrome (CYP)1,
CYP2 and CYP3 families in 22 different
human tissues. Pharmacogenet Genomics
2007;17:731-42.
13. Komori M, Nishio K, Kitada M, et al. Fetus-
specific expression of a form of
cytochrome P-450 in human livers. Bio -
chemistry 1990;29:4430-3.
14. Yang HY, Lee QP, Rettie AE, Juchau MR.
Functional cytochrome P4503A isoforms in
human embryonic tissues: expression dur-
ing organogenesis. Mol Pharmacol 1994;
46:922-8.
15. Cresteil T. Onset of xenobiotic metabolism
in children: toxicological implications.
Food Addit Contam 1998;15 Suppl:45-51.
16. Nishimura M, Yaguti H, Yoshitsugu H, et
al. Tissue distribution of mRNA expres-
sion of human cytochrome P450 isoforms
assessed by high-sensitivity real-time
reverse transcription PCR. Yakugaku
Zasshi 2003;123:369-75.
17. Guengerich FP. Cytochrome P-450 3A4:
regulation and role in drug metabolism.
Annu Rev Pharmacol Toxicol 1999;39:1-17.
18. Shang H, Yang J, Liu Y, Wei H. Tissue dis-
tribution of CYP3A29 mRNA expression in
Bama miniature pig by quantitative
reverse transcriptase-polymerase chain
reaction (RT-PCR). Xenobiotica 2009;39:
423-9.
19. Skaanild MT, Friss C. Characterization of
the P450 system in Göttingen minipigs.
Pharmacol Toxicol 1997;80 Suppl 2:28-33.
20 Anzenbacherova E, Baranova J, Zuber R, et
al. Model systems based on experimental
animals for studies on drug metabolism in
man: (mini)pig cytochromes P450 3A29
and 2E1. Basic Clin Pharmacol Toxicol
2005;96:244-5.
21. Organisation for Economic Cooperation
and Development (OECD): OECD guide-
line for the testing of chemicals. Proposal
for updating guideline 414. Prenatal devel-
Article
No
n-c
om
me
rci
al
u
e 
nly
[Journal of Xenobiotics 2011; 1:e1] [page 5]
opmental toxicity study. Adopted 22nd
January 2001. Available from: http://www.
oecd.org/dataoecd/18/15/1948482.pdf
22. Schardein JL, Schwetz BA, Kenel MF.
Species sensitivities and prediction of
tetratogenic potential. Environ Health
Perspect 1985;61:55-67.
23. Gillberg M, Skaanild MT, Friis C.
Regulation of gender-dependent CYP2A
expression in pigs: involvement of andro-
gens and CAR. Basic Clin Pharmacol
Toxicol 2006;98:480-7.
24. Leeder JS, Gaedigk R, Marcucci KA, et al.
Variability of CYP3A7 expression in
human fetal liver. J Pharmacol Exp Ther
2005;314:626-35.
25. Nygard AB, Jorgensen CB, Cirera S,
Fredholm M. Selection of reference genes
for gene expression studies in pig tissues
using SYBR green qPCR. BMC Mol Biol
2007;8:67.
26. U.S. National Library of Medicine.
National Center for Biotechnology
Information, NCBI. Available from:
http://www.ncbi.nlm.nih.gov/  Accessed:
October 2009.
27. Fox J. R Commander. Package ‘Rcmdr’ ver-
sion 1.5-4. 2009. Available from:
http://cs.swan.ac.uk/~csoliver/ok-sat-
library/OKplatform/ExternalSources/sourc
es/R/packages/Rcmdr.pdf
28. Marill J, Capron CC, Idres N, Chabot GG.
Human cytochrome P450s involved in the
metabolism of 9-cis- and 13-cis-retinoic
acids. Biochem Pharmacol 2002;63:933-43.
29. Stevens JC, Hines RN, Gu C, et al. Develop -
mental expression of the major human
hepatic CYP3A enzymes. J Pharmacol Exp
Ther 2003;307:573-82.
30. Schuetz JD, Beach DL, Guzelian PS. Selective
expression of cytochrome P450 CYP3A
mRNAs in embryonic and adult human liver.
Pharmacogenetics 1994;4:11-20.
Article
No
n-c
om
me
rci
al 
us
e o
nly
